Abstract
L-Theanine is commonly used to improve sleep quality through inhibitory neurotransmitters. On the other hand, Mg<sup>2+</sup>, a natural NMDA antagonist and GABA agonist, has a critical role in sleep regulation. Using the caffeine-induced brain electrical activity model, here we investigated the potency of L-theanine and two novel Mg-L-theanine compounds with different magnesium concentrations on electrocorticography (ECoG) patterns, GABAergic and serotonergic receptor expressions, dopamine, serotonin, and melatonin levels. Furthermore, we evaluated the sleep latency and duration in the pentobarbital induced sleep model. We herein showed that L-theanine, particularly its various complexes with magnesium increases the expression of GABAergic, serotonergic, and glutamatergic receptors, which were associated with decreased ECoG frequency, increased amplitude, and enhanced delta wave powers. Besides increased dopamine, serotonin, and melatonin; decreased MDA and increased antioxidant enzyme levels were also observed particularly with Mg-complexes. Protein expression analyses also showed that Mg-L-theanine complexes decrease inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) levels significantly. In accordance with these results, Mg complexes improved the sleep latency and duration even after caffeine administration. As a result, our data indicate that Mg-L-theanine compounds potentiate the effect of L-theanine on sleep by boosting slow-brain waves, regulating brain electrical activity, and increasing neurotransmitter and GABA receptor levels.
Introduction
Sleep disturbances affect a massive portion of the global population, contributing to significant morbidity and mortality. While pharmacological interventions like benzodiazepines exist, they are often plagued by side effects such as dependency, memory impairment, and "hangover" effects.
Natural alternatives like L-theanine (an amino acid found in green tea) and Magnesium ($Mg^{2+}$) are known to promote relaxation, but their individual potency can be limited. Researchers have developed a novel magnesium-L-theanine (Mg-L-Theanine) complex that aims to provide a synergistic effect. By combining the NMDA-antagonistic properties of magnesium with the neurotransmitter-modulating effects of theanine, this complex seeks to boost slow-wave (delta) brain activity and mitigate insomnia more effectively than standard L-theanine.
Methods
The study utilized male Balb/c mice across two primary experimental sets to evaluate the efficacy of L-theanine and two novel complexes: Mg-T1 (8% $Mg^{2+}$) and Mg-T2 (18% $Mg^{2+}$).
Experimental Protocols
- Brain Electrical Activity (ECoG): Mice ($n=6$ per group) were anesthetized, and electrodes were placed on the somatomotor cortex. Sleep disturbance was induced using caffeine, followed by administration of saline, L-theanine, Mg-T1, or Mg-T2. Researchers measured spike frequency, amplitude, and power spectral density, specifically focusing on delta waves.
- Sleep Behavioral Models: Using a pentobarbital-induced sleep model ($n=8$ per group), the team measured sleep latency (time to fall asleep) and sleep duration (time until the righting reflex is regained).
- Biochemical Analysis:
- Western Blotting: Quantified the expression of GABAergic ($GABA_A$, $GABA_B$), serotonergic ($5-HT_{1A}$), and glutamatergic (GluA1, GluN1, GluN2A) receptors.
- ELISA: Measured levels of dopamine, serotonin, and melatonin.
- Oxidative Stress Markers: Assessed neuroprotective effects by measuring antioxidant enzymes (SOD, CAT, GPx) and malondialdehyde (MDA).
Key Insights and Results
The Mg-L-Theanine complex proved to be more than the sum of its parts, demonstrating significant synergistic potentiation.
Restoration of Sleep Architecture
Caffeine typically suppresses slow-wave brain activity. The Mg-complexes (particularly Mg-T2) significantly boosted delta wave power (0.5–4 Hz), which is the hallmark of deep, restorative NREM sleep. In the caffeine-induced insomnia model, Mg-T2 reduced sleep latency and increased sleep duration significantly more than L-theanine alone. ECoG patterns showed that the complexes reversed the high-frequency "spiking" caused by caffeine, shifting the brain back toward a low-frequency, high-amplitude state.
Neurotransmitter and Receptor Modulation
The complex didn't just increase neurotransmitter levels; it significantly upregulated the expression of $GABA_A$ and $GABA_B$ receptors, as well as $5-HT_{1A}$ (serotonin) receptors. Mg-T2 showed the highest elevation of dopamine, serotonin, and melatonin levels compared to the caffeine control. This creates a more robust inhibitory environment in the brain conducive to sleep.
Neuroprotection and Dose-Dependency
Beyond sleep, the complexes reduced oxidative stress markers (MDA) and inflammatory markers (iNOS and eNOS) more effectively than L-theanine alone. The results were generally dose-dependent, with the higher magnesium concentration (Mg-T2, 18%) showing superior results across most metrics compared to the 8% version (Mg-T1).
Limitations and Future Work
While the murine results are promising, several factors must be considered for future research:
- Anesthesia Interference: ECoG recordings were performed under urethane anesthesia, which can alter baseline brain activity. Future studies should involve recordings in naturally moving, non-anesthetized animals.
- Acute vs. Chronic Effects: This study focused on acute administration. The long-term effects, potential for tolerance, or metabolic changes over chronic usage remain unknown.
- Human Translation: Clinical trials are required to confirm if the Mg-L-Theanine complex translates to improved sleep quality in humans without adverse effects.
- Transport Kinetics: The specific kinetics of how the complex passes the blood-brain barrier compared to its individual components could be explored further.
Summary updated